Close Menu

NEW YORK ─ Bio-Techne said on Tuesday that its Exosome Diagnostics business has obtained the CE mark for the firm's ExoDx Prostate test (EPI) kit, an exosomal liquid biopsy diagnostic assay, enabling its use in the European Union and other regions that accept the designation.

The Minneapolis-based firm added it will begin running the urine-based test immediately in its clinical laboratory in Munich and make it available throughout Europe through various distribution channels.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.